A study by a team of researchers has shown that the children most likely to be diagnosed with ADHD are the youngest children in the classroom. The systematic review used seventeen studies covering more than 14 million children from various countries. The review was published in the Journal of Child Psychology and Psychiatry. The findings are damning for the pharmaceutical industry and medical community who have pushed medication on kids for just being kids.

Being the youngest kid in class is not the only variation when it comes to the diagnosis, the diagnosis also varies from one country to another, one region to another. In France ADHD is extremely rare, while it has grown to 10% of children over the age of three in the U.S. Children in Appalachia are more likely than children in California to be diagnosed—23 percent of school-aged boys in the South have received a diagnosis.

A recent brochure on ADHD from The National Institutes of Mental Health (NIMH) tries to promote the idea of ADHD all the while not mentioning that the studies they use only detected minuscule differences in a group of children, far too small to be statistically significant.

The study’s findings suggest that sex, citizenship, state of residence, and now birth-date have all been shown to play a role in who receives a diagnosis. The medical community has mislabeled normal brain development as a pathology and society has fallen victim to quackery, leading to doctors drugging kids for being kids.

Photo: “Bird on a wire? No. Boy on a wall.” by Ken Banks is licensed under CC BY 2.0